Clinical Trial Update: TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic [Phase 4]

View source ↗

Summary

Phase 4 trial update on pharmacogenetic-guided tacrolimus dosing for kidney transplant patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED